Market Research Reports
Resources
About
Cart (0)

Renal Disease Treatments: Products and Therapies

Report Code: HLC073A

Publish Date: Nov 2009

Publisher: BCC Publishing

Category: Health Maintenance

Customize This Report

Single User License: $2750

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

  • Overall sales in the global market for renal failure treatmentwere worth nearly $28 billion in 2009, it is estimated to increase to $33.5 billion at a 5 year compound annual growth rate (CAGR) of 3.7%.
  • The largest segment CKD treatment products and therapies (including dialysis consumables) market was nearly $26.5 billion in 2009. This is expected to rise to $31.7 billion in 2014, at a CAGR of 3.6%.
  • ARF treatment products and therapies (including dialysis consumables) market reached $955 million in 2009 and is projected to reach $1.4 billion in 2014, at a CAGR of 8.7%.

INTRODUCTION 

STUDY GOAL AND OBJECTIVES
 
This BCC Research market opportunity study provides an in-depth analysis of the market for kidney failure treatment products and services, forecasting growth and trends in the various sectors over the next 5 years. Products and services will include those for treating acute renal failure, chronic renal failure, and end-stage renal disease, the final phase of chronic kidney failure.
Market sectors to be covered in this report include pharmaceuticals used to address the conditions associated with kidney failure (i.e., hypertension, diabetes, and anemia); hemodialysis and peritoneal dialysis products and services; and surgical procedures used to keep the end-stage kidney patient alive (i.e., surgeries to create vascular access sites for dialysis, and kidney transplantation).
The conclusions are illustrated with important statistical and analytical information on markets, industry structure and dynamics, as well as technological developments.
REASONS FOR DOING THE STUDY
 
Kidney failure is the ninth-leading cause of death in the U.S., accounting for about 85,000 fatalities each year. Approximately 27 million Americans currently have chronic kidney disease, while another 20 million are at increased risk for developing chronic kidney disease. More than 500,000 individuals currently are being treated for kidney failure via dialysis or kidney transplant. Nearly 400,000 individuals receive dialysis treatments three or more times each week. Over the last decade, the chronic kidney disease rate has risen more than 25%. During the past 5 years, the number of new patients with kidney failure has averaged 90,000 to more than 100,000 annually.
In addition to the individuals struggling with chronic kidney disease, more than 200,000 people suffer acute renal failure in the U.S. each year. The rate of ARF diagnosis as a percentage of all kidney failure hospitalizations rose from 7.3% in 1980 to 60% in 2005. Experts note that some of the increase may be due to changes in the definition of acute renal failure. Many of these patients acquire the condition while already hospitalized for other problems. While sometimes temporary and reversible, acute renal failure also may lead to chronic kidney failure.
The total annual cost of treating end-stage renal disease caused by either chronic kidney disease or acute renal failure is in the tens of billions of dollars each year. Much of the care for chronic kidney disease and end-stage renal disease is provided in the outpatient setting; however, the number of hospitalizations for acute renal failure and chronic kidney failure is substantial.
Over the past 20 years, both the numbers and rates of kidney disease hospital discharges have increased, especially among adults age 65 years or older. In addition, a shift has occurred for reported hospitalizations in the type of kidney disease, from chronic to acute renal failure. An increasing number of kidney disease hospitalizations also are associated with a concomitant diagnosis of diabetes mellitus or hypertension.
For both acute and chronic conditions, and outpatient or in-hospital settings, nearly all of these kidney problems require some sort of intervention, whether pharmaceutical, mechanical, and/or surgical. This report details the various products and services used to address renal failure. Three categories of treatment are most prevalent: prescription medications, dialysis (hemodialysis, peritoneal dialysis, and continuous renal replacement therapy), and surgical intervention, which are often used in combination to treat a single case of renal failure.
INTENDED AUDIENCE
This study aims to provide those interested in investment, acquisition, or expansion into the renal failure treatment market with specific, detailed information crucial to making informed decisions. Senior marketing personnel, venture capitalists, executive planners, and research directors should find the report of value. Readers who simply wish to understand how regulations, market pressures, and technology interact in the renal failure treatment industry also will find the study worthwhile.
SCOPE OF REPORT 
 
Five-year projections for market activity and value are provided. Treatment types and trends for acute and chronic renal failure, pricing considerations for medications, dialysis products (dialysis machines, dialysates and dialyzers) and therapies, and surgical procedures; companies, industry structure and participating companies are included in the study.
Not included in the study are market analyses for water treatment systems used in making dialysate solutions, or lower-cost dialysis supplies such as fistula needles, bloodlines, topical anesthetics, wipes, bandages, dressings, etc. Diagnostics, testing, and other lab services are not included, nor are training sessions for home hemodialysis or peritoneal dialysis. For hospitalizations related to acute renal failure and vascular access maintenance, therapy/surgical costs reflect, as much as possible, only those expenses directly related to kidney care. Charges for the stay in intensive care, ventilation, laboratory services, and drugs not directly related to renal failure treatment are not included. Ambulance costs, nursing home expenses, and non-nephrology-related physician fees also are excluded.
INFORMATION SOURCES
 
Research for this report began with an in-depth analysis of technical and business literature, as well as a review of the history of the technology. Information from industry experts, company representatives, government researchers, and university scientists provided the basis for an assessment of the industry. Specific information sources include company annual reports, the Centers for Disease Control and Prevention, U.S. Renal System Database, National Kidney Foundation, Organ Procurement and Transplantation Network, Network 13, National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health, National Kidney Disease Education Program, product literature from pharmaceutical and equipment manufacturers, scientific journals, and patent searches. 
The study is divided into key chapters dealing with the three types of interventions used in treating kidney failure: medication, dialysis, and surgery. The report makes projections for each market in terms of constant 2009 dollars. Historical values are presented for the given year, with focus on the U.S. market. Overseas activity is mentioned briefly in order to put the U.S. market into a global context.
ANALYST CREDENTIALS
 
During the past 13 years, Susan Hanft has authored more than 14 BCC market opportunity reports in the fields of membrane technology, medical devices, water and wastewater treatment, and bioenergy.
BCC ONLINE SERVICES
 
BCC offers an online information retrieval service. BCC’s home page, located at www.bccresearch.com, enables readers to:
  • Examine BCC’s complete catalog of Market Research Reports and place direct orders
  • Subscribe to any of BCC’s many industry newsletters
  • Read announcements of recently published reports and newly launched newsletters
  • Register for BCC’s well-known conferences
  • Request additional information on any BCC product
  • Take advantage of special offers
DISCLAIMER 

The information developed in this report is intended to be as reliable as possible at the time of publication and of a professional nature. This information does not constitute managerial, legal, or accounting advice; nor should it serve as a corporate policy guide, laboratory manual, or an endorsement of any product, as much of the information is speculative in nature. The author assumes no responsibility for any loss or damage that might result from reliance on the reported information or its use.

Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW
Let us assist you! Our analysts are ready to tailor this report to your specific need. REACH OUT TO US TODAY

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
[+] Show Chapter Details
Title/Chapter NamePagesMember Price
Full Report: Renal Disease Treatments: Products and Therapies188Free
Chapter- 1: INTRODUCTION4Free
Chapter- 2: SUMMARY3Free
Chapter- 3: OVERVIEW12Free
Chapter- 4: ACUTE KIDNEY FAILURE11Free
Chapter- 5: CHRONIC KIDNEY FAILURE17Free
Chapter- 6: PHARMACEUTICALS USED IN RENAL FAILURE TREATMENT33Free
Chapter- 7: RENAL REPLACEMENT PRODUCTS AND THERAPIES USED IN KIDNEY FAILURE TREATMENT37Free
Chapter- 8: SURGICAL PROCEDURES USED IN RENAL FAILURE TREATMENT12Free
Chapter- 9: THE INTERNATIONAL MARKET7Free
Chapter- 10: INDUSTRY STRUCTURE52Free

Related Reports

Recent Reports

Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - HLC078F

The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.

Global Markets for Emerging Insulin Drug and Delivery Technologies: Focus on Syringes and Vials

Published - Mar 2024 | Publisher - Bejini Sandeep Kumar | Code - HLC156B

The global market for emerging insulin drug delivery devices is expected to grow from $55.8 billion in 2023 and projected to reach $88.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.8% from 2023 through 2028.

Global Cleanroom Technology Market

Published - Mar 2024 | Publisher - BCC Publishing | Code - HLC298A

The global market for cleanroom products is expected to grow from $7.5 billion in 2023 to $10.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.6% from 2023 through 2028.

Ophthalmic Devices, Diagnostics and Surgical Equipment: Global Markets

Published - Mar 2024 | Publisher - BCC Publishing | Code - HLC083D

The global market for ophthalmic devices, diagnostics and surgical equipment is expected to grow from $32.5 billion in 2023 and forecast to reach $44.0 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.3% from 2023 to 2028.

Microelectromechanical Systems (MEMS) in Global Medical Markets

Published - Mar 2024 | Publisher - BCC Publishing | Code - HLC129B

The global market for microelectromechanical systems (MEMS) devices in medical applications is estimated to increase from $4.8 billion in 2023 to reach $7.2 billion by 2028, at a compound annual growth rate (CAGR) of 8.5% from 2023 through 2028.

Top Trending Reports

Cell and Gene Therapy Tools, and Reagents: Global Markets

Published - Nov 2022 | Publisher - BCC Publishing | Code - BIO208B

The global market for cell and gene therapy tools and reagents is estimated to grow from $8.3 billion in 2022 to $13.7 billion in 2027, with a compound annual growth rate (CAGR) of 10.6% for the period of 2022-2027.

ESG Trends in Chemical Industry

Published - Dec 2022 | Publisher - BCC Publishing | Code - ENV056A

This report focuses on the ESG trends in the chemical industry and evaluates the ESG implementation including current and future potential. The report utilizes various databases, including sustainability reports, annual reports, and other indicators used to develop the current market. The study provides detailed information on the main factors influencing ESG growth in the chemical industry. It enables the reader to understand the industry in general while also providing insight into the inter-relationship between ESG and the sustainable chemical industry. The report describes market growth, developing trends, industry leaders, and applications of ESG implementation in the  chemical industry.

Digital Pathology: Technologies and Global Markets

Published - Dec 2022 | Publisher - BCC Publishing | Code - HLC161D

The global digital pathology market is estimated to increase from $5.9 billion in 2022 to reach $10.7 billion by 2027, at a compound annual growth rate (CAGR) of 12.5% from 2022 through 2027.

Smartphone-Based Patient Monitoring: Global Market

Published - Nov 2022 | Publisher - BCC Publishing | Code - HLC285A

The global smartphone-based patient monitoring market should reach $21.5 billion by 2027 from $6.8 billion in 2022 at a compound annual growth rate (CAGR) of 25.9% for the forecast period of 2022 to 2027.

Non-Fungible Tokens (NFT): Global Market

Published - Nov 2022 | Publisher - BCC Publishing | Code - IFT248A

The global NFTs market should reach $37.6 billion by 2022 and $125.6 billion by 2027, with a compound annual growth rate (CAGR) of 27.3% during the forecast period of 2022-2027.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Renal Disease Treatments: Products and Therapies
Customize This Report
Customize Report
Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, MA for over 50 years, we are your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, to better understand their field and target audience. We are dedicated to helping companies access reliable information, accurate forecasts, and actionable insights, to become leaders in their industry.
Contact
© 2024 BCC Research
Privacy Policy |Site Map|Terms & Conditions